Date: 2013-06-26
Type of information: Private placement
Company: Biotest (Germany)
Investors:
Amount: € 76 million
Funding type: private placement
Planned used:
Others: * On June 26, 2013, Biotest has announced the successful completion of the capital increase: the maximum amount of 1,461,909 new preference shares at a price of € 52 per share were acquired by shareholders exercising their subscription rights or were placed with institutional investors due to high interest in the share. The gross proceeds of the issue amount to € 76 million.
Therapeutic area:
